Fadar Oliver Otite

Fadar Oliver Otite

Auto-generated profile, based on publicly available information

Fadar Oliver Otite

State University of New York Upstate Medical University, Syracuse

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2016 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
FIFumiaki Imamura
Fumiaki Imamura
RMRenata Micha
Renata Micha
JWJason Wu
Jason Wu
MOMarcia C. de Oliveira Otto
Marcia C. de Oliveira Otto
FOFadar O. Otite
Fadar O. Otite
DMDariush Mozaffarian
Dariush Mozaffarian
Effects of major dietary macronutrients on glucose-insulin homeostasis remain controversial and may vary by the clinical measures examined. We aimed to assess how saturated fat (SFA), monounsaturated fat (MUFA), polyunsaturated fat (PUFA), and carbohydrate affect key metrics of glucose-insulin homeostasis. We systematically searched multiple databases (PubMed, EMBASE, OVID, BIOSIS, Web-of-Knowledge, CAB, CINAHL, Cochrane Library, SIGLE, Faculty1000) for randomised controlled feeding trials published by 26 Nov 2015 that tested effects of macronutrient intake on blood glucose, insulin, HbA1c, insulin sensitivity, and insulin secretion in adults aged ≥18 years. We excluded trials with non-isocaloric comparisons and trials providing dietary advice or supplements rather than meals. Studies were reviewed and data extracted independently in duplicate. Among 6,124 abstracts, 102 trials, including 239 diet arms and 4,220 adults, met eligibility requirements. Using multiple-treatment meta-regression, we estimated dose-response effects of isocaloric replacements between SFA, MUFA, PUFA, and carbohydrate, adjusted for protein, trans fat, and dietary fibre. Replacing 5% energy from carbohydrate with SFA had no significant effect on fasting glucose (+0.02 mmol/L, 95% CI = -0.01, +0.04; n trials = 99), but lowered fasting insulin (-1.1 pmol/L; -1.7, -0.5; n = 90). Replacing carbohydrate with MUFA lowered HbA1c (-0.09%; -0.12, -0.05; n = 23), 2 h post-challenge insulin (-20.3 pmol/L; -32.2, -8.4; n = 11), and homeostasis model assessment for insulin resistance (HOMA-IR) (-2.4%; -4.6, -0.3; n = 30). Replacing carbohydrate with PUFA significantly lowered HbA1c (-0.11%; -0.17, -0.05) and fasting insulin (-1.6 pmol/L; -2.8, -0.4). Replacing SFA with PUFA significantly lowered glucose, HbA1c, C-peptide, and HOMA. Based on gold-standard acute insulin response in ten trials, PUFA significantly improved insulin secretion capacity (+0.5 pmol/L/min; 0.2, 0.8) whether replacing carbohydrate, SFA, or even MUFA. No significant effects of any macronutrient replacements were observed for 2 h post-challenge glucose or insulin sensitivity (minimal-model index). Limitations included a small number of trials for some outcomes and potential issues of blinding, compliance, generalisability, heterogeneity due to unmeasured factors, and publication bias. This meta-analysis of randomised controlled feeding trials provides evidence that dietary macronutrients have diverse effects on glucose-insulin homeostasis. In comparison to carbohydrate, SFA, or MUFA, most consistent favourable effects were seen with PUFA, which was linked to improved glycaemia, insulin resistance, and insulin secretion capacity.

18 April 2023 in Circulation
Verified
Journal Article
Closed access
KAKaiz S Asif
Kaiz S Asif
FOFadar O Otite
Fadar O Otite
SDShashvat M Desai
Shashvat M Desai
NHNabeel Herial
Nabeel Herial
VIVioliza Inoa
Violiza Inoa
GSGlobal Executive Committee of the MT-GLASS Study
Global Executive Committee of the MT-GLASS Study
Background: Despite the well-established potent benefit of mechanical thrombectomy (MT) for large vessel occlusion (LVO) stroke, access to MT has not been studied globally. We conducted a worldwide survey of countries on 6 continents to define MT access (MTA), the disparities in MTA, and its determinants on a global scale. Methods: Our survey was conducted in 75 countries through the Mission Thrombectomy 2020+ global network between November 22, 2020, and February 28, 2021. The primary end points were the current annual MTA, MT operator availability, and MT center availability. MTA was defined as the estimated proportion of patients with LVO receiving MT in a given region annually. The availability metrics were defined as ([current MT operators×50/current annual number of estimated thrombectomy-eligible LVOs]×100 = MT operator availability) and ([current MT centers×150/current annual number of estimated thrombectomy-eligible LVOs]×100= MT center availability). The metrics used optimal MT volume per operator as 50 and an optimal MT volume per center as 150. Multivariable-adjusted generalized linear models were used to evaluate factors associated with MTA. Results: We received 887 responses from 67 countries. The median global MTA was 2.79% (interquartile range, 0.70–11.74). MTA was <1.0% for 18 (27%) countries and 0 for 7 (10%) countries. There was a 460-fold disparity between the highest and lowest nonzero MTA regions and low-income countries had 88% lower MTA compared with high-income countries. The global MT operator availability was 16.5% of optimal and the MT center availability was 20.8% of optimal. On multivariable regression, country income level (low or lower–middle versus high: odds ratio, 0.08 [95% CI, 0.04–0.12]), MT operator availability (odds ratio, 3.35 [95% CI, 2.07–5.42]), MT center availability (odds ratio, 2.86 [95% CI, 1.84–4.48]), and presence of prehospital acute stroke bypass protocol (odds ratio, 4.00 [95% CI, 1.70–9.42]) were significantly associated with increased odds of MTA. Conclusions: Access to MT on a global level is extremely low, with enormous disparities between countries by income level. The significant determinants of MT access are the country’s per capita gross national income, prehospital LVO triage policy, and MT operator and center availability.

26 August 2020 in Neurology
Verified
Journal Article
Closed access
PDF file
FOFadar Oliver Otite
Fadar Oliver Otite
SPSmit Patel
Smit Patel
RSRicha Sharma
Richa Sharma
PKPushti Khandwala
Pushti Khandwala
DDDevashish Desai
Devashish Desai
SCSeemant Chaturvedi
Seemant Chaturvedi
Objective To test the hypothesis that race-, age-, and sex-specific incidence of cerebral venous thrombosis (CVT) has increased in the United States over the last decade. Methods In this retrospective cohort study, validated ICD codes were used to identify all new cases of CVT (n = 5,567) in the State Inpatients Databases (SIDs) of New York and Florida (2006–2016). A new CVT case was defined as first hospitalization for CVT in the SID without prior CVT hospitalization. CVT counts were combined with annual Census data to compute incidence. Joinpoint regression was used to evaluate trends in incidence over time. Results From 2006 to 2016, annual age- and sex-standardized incidence of CVT in cases per 1 million population ranged from 13.9 to 20.2, but incidence varied significantly by sex (women 20.3–26.9, men 6.8–16.8) and by age/sex (women 18–44 years of age 24.0–32.6, men 18–44 years of age 5.3–12.8). Incidence also differed by race (Blacks: 18.6–27.2; Whites: 14.3–18.5; Asians: 5.1–13.8). On joinpoint regression, incidence increased across 2006 to 2016, but most of this increase was driven by an increase in all age groups of men (combined annualized percentage change [APC] 9.2%, p < 0.001), women 45 to 64 years of age (APC 7.8%, p < 0.001), and women ≥65 years of age (APC 7.4%, p < 0.001). Incidence in women 18 to 44 years of age remained unchanged over time. Conclusion CVT incidence is disproportionately higher in Blacks compared to other races. New CVT hospitalizations increased significantly over the last decade mainly in men and older women. Further studies are needed to determine whether this increase represents a true increase from changing risk factors or an artifactual increase from improved detection.

1 August 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
FOFadar Oliver Otite
Fadar Oliver Otite
VSVasu Saini
Vasu Saini
NSNicole Beaton Sur
Nicole Beaton Sur
SPSmit Patel
Smit Patel
RSRicha Sharma
Richa Sharma
SCSeemant Chaturvedi
Seemant Chaturvedi
Background and Purpose: IV tPA (intravenous thrombolysis with alteplase) and mechanical thrombectomy (MT) utilization increased in acute ischemic stroke hospitalizations in the United States over the last decade. It is uncertain whether this increase occurred equally across all age, sex, and racial groups. Methods: Adult acute ischemic stroke hospitalizations (weighted n=4 442 657) contained in the 2008 to 2017 National Inpatient Sample were identified using International Classification of Diseases codes. Proportions of hospitalizations with IV tPA and MT were computed according to age, sex, and race. Joinpoint and multivariable-adjusted logistic regression models were used to evaluate trends over time. Results: Across this period, 32.4% of all hospitalizations were in patients ≥80 years, and 64.7% of these were women. IV tPA and MT use differed by age with highest proportion of utilization of both treatments in patients aged 18 to 39 years (IV tPA, 12.3%) and lowest percentage in patients aged ≥90 years (IV tPA, 7.9%). Utilization of both procedures increased over time in all age groups, but the pace of increase was faster in patients ≥90 years compared with patients aged 18 to 39 years (MT: odds ratio, 1.25 [95% CI, 1.20–1.35] per unit increase in year, P interaction 10% in all demographic subgroups except in Black patients 60 to 79 years and Black patients ≥80 years. Analysis of race-by-time interaction revealed the Black-vs-White treatment gaps for IV tPA (odds ratio, 1.02 [95% CI, 1.01–1.03]) and MT (odds ratio, 1.08 [95% CI,1.05–1.12]) declined over time (both P interaction <0.01). Sex-related differences in IV tPA use were noted, but this gap also declined over time. Conclusions: Age- and sex-related treatment gaps in IV tPA and MT reduced over the last decade. Racial disparity in IV tPA and MT utilization persists with particularly lower frequency of usage of both acute stroke treatments in Black patients compared with White patients, but race-associated treatment gaps also declined over time.

21 March 2023 in Neurology
Verified
Journal Article
Closed access
PDF file
RARashid Ahmed
Rashid Ahmed
CMCarl Mhina
Carl Mhina
KPKaran Philip
Karan Philip
SPSmit D. Patel
Smit D. Patel
EAEhimen Aneni
Ehimen Aneni
FOFadar Oliver Otite
Fadar Oliver Otite
Objective: To test the hypothesis that the age and sex-specific prevalence of infectious [pneumonia, sepsis, and urinary tract infection (UTI)] and non-infectious [deep venous thrombosis (DVT), pulmonary embolism (PE), acute renal failure (ARF), acute myocardial infarction (AMI), gastrointestinal bleeding (GIB)] complications increased following acute ischemic stroke (AIS) hospitalization in the United States (US) from 2007- 2019. Methods: We conducted a serial cross-sectional study using the 2007-2019 National Inpatient Sample. Primary AIS admissions in adults (≥18 years) with and without complications were identified using International Classification of Diseases Codes. We quantified the age/sex-specific prevalence of complications and used negative binomial regression models to evaluate trends over time. Results: Of 5,751,601 weighted admissions, 51.4% were women. 25.1% had at least one complication. UTI (11.8%), ARF (10.1%), pneumonia (3.2%) and AMI (2.5%) were the most common complications, while sepsis (1.7%), GIB (1.1%), DVT (1.2%), and PE (0.5%) were the least prevalent. Marked disparity in complication risk existed by age/sex (UTI: men 18-39 years 2.1%; women ≥80 years 22.5%). Prevalence of UTI (12.9% to 9.7%) and pneumonia (3.8% to 2.7%) declined, but that of ARF increased by ≈3-fold (4.8% to 14%) over the period 2007-2019, (all p <0.001). AMI (1.9% to 3.1%), DVT (1.0% to 1.4%), and PE (0.3% to 0.8%) prevalence also increased (p<0.001), but that of sepsis and GIB remained unchanged over time. After multivariable adjustment, risk of all complications increased with increasing National Institute of Health Stroke Scale (Pneumonia, prevalence rate ratio [PRR] 1.03, 95%CI 1.03-1.04, for each unit increase), but intravenous thrombolysis was associated with reduced risk of all complications (pneumonia: PRR 0.80, 85%CI 0.73-0.88; AMI: PRR 0.85, 95%CI 0.78-0.92; DVT PRR 0.87, 95%CI 0.78-0.98). Mechanical thrombectomy was associated with reduced risk of UTI, sepsis, and ARF but DVT and PE were more prevalent in MT hospitalizations compared to those without. All complications except UTI were associated with increased risk of in-hospital mortality (sepsis: PRR 1.97, 95%CI 1.78-2.19). Conclusion: Infectious complications declined, but noninfectious complications, increased following AIS admissions in the US in the last decade. Utilization of intravenous thrombolysis is associated with reduced risk of all complications.

7 November 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
FOFadar Oliver Otite
Fadar Oliver Otite
NLNicholas Liaw
Nicholas Liaw
PKPriyank Khandelwal
Priyank Khandelwal
AMAmer M. Malik
Amer M. Malik
JRJose G. Romano
Jose G. Romano
SCSeemant Chaturvedi
Seemant Chaturvedi
Objective: To evaluate trends in prevalence of cardiovascular risk factors (hypertension, diabetes, dyslipidemia, smoking, and drug abuse) and cardiovascular diseases (carotid stenosis, chronic renal failure [CRF], and coronary artery disease [CAD]) in acute ischemic stroke (AIS) in the United States. Methods: We used the 2004–2014 National Inpatient Sample to compute weighted prevalence of each risk factor in hospitalized patients with AIS and used joinpoint regression to evaluate change in prevalence over time. Results: Across the 2004–2014 period, 92.5% of patients with AIS had ≥1 risk factor. Overall age- and sex-adjusted prevalence of hypertension, diabetes, dyslipidemia, smoking, and drug abuse were 79%, 34%, 47%, 15%, and 2%, respectively, while those of carotid stenosis, CRF, and CAD were 13%, 12%, and 27%, respectively. Risk factor prevalence varied by age (hypertension: 44% in 18–39 years vs 82% in 60–79 years), race (diabetes: Hispanic 49% vs white 30%), and sex (drug abuse: men 3% vs women 1.4%). Using joinpoint regression, prevalence of hypertension increased annually by 1.4%, diabetes by 2%, dyslipidemia by 7%, smoking by 5%, and drug abuse by 7%. Prevalence of CRF, carotid stenosis, and CAD increased annually by 13%, 6%, and 1%, respectively. Proportion of patients with multiple risk factors also increased over time. Conclusions: Despite numerous guidelines and prevention initiatives, prevalence of hypertension, diabetes, dyslipidemia, smoking, and drug abuse in AIS increased across the 2004–2014 period. Proportion of patients with carotid stenosis, CRF, and multiple risk factors also increased. Enhanced risk factor modification strategies and implementation of evidence-based recommendations are needed for optimal stroke prevention.